STAAR Surgical | STAA - Gross Profit On Sales


STAAR Surgical reported $43.74M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Abbott USD 5.86B 675M Mar/2026
Bausch Health Companies USD 2B 67M Dec/2025
Boston Scientific USD 3.61B 64M Mar/2026
Cerus USD 33.33M 8.66M Dec/2024
Cooper Companies USD 695.2M 44.4M Dec/2025
J&J USD 17.24B 642M Mar/2026
Merit Medical Systems USD 184.8M 10.56M Mar/2026
Novartis USD 10.07B 184M Mar/2026
OraSure Technologies USD 11.34M 435K Dec/2025
Orthofix International USD 153.28M 4.76M Dec/2025
Rockwell Medical USD 4.55M 1.49M Jun/2024
STAAR Surgical USD 43.74M 34.13M Dec/2025
Utah Medical Products USD 5.8M 450K Sep/2024